ClinicalTrials.Veeva

Menu

Post-operative Pain Reduction

M

Minia University

Status

Unknown

Conditions

Effects of the Elements

Treatments

Drug: Conventional calcium hydroxide paste
Drug: Calcium hydroxide nanoparticle
Drug: Combined Calcium hydroxide with silver nanoparticle

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Recruited patients with necrotic pulp after application of conventional calcium hydroxide paste are assigned to group, Calcium hydroxide nanoparticle group and Combined Calcium hydroxide with silver nanoparticle group and record postoperative pain afterwards.

Full description

The investigator will recruit patients who are found eligible to the criteria, conventional calcium hydroxide paste , Calcium hydroxide nanoparticle and Combined Calcium hydroxide with silver nanoparticle . After 48 hours, patients will be randomly assigned to removal of intracanal medication

After the visit, patients will be asked to record post operative pain by Numerical Rating Scale)in a given sheet

Enrollment

30 estimated patients

Sex

All

Ages

25 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • • Medically free patients.

    • Patient's age between 25-50 years.
    • Sex includes both male and female.
    • Radiographic evidence of a periapical radiolucent lesion associated with tooth.
    • Necrotic pulp as indicated by thermal pulp testing.
    • No history of previous endodontic treatment of the tooth.

Exclusion criteria

  • • Teeth with unfavorable conditions for rubber-dam application.

    • Teeth with acute periapical abscesses swelling.
    • Medically compromised patients.
    • Immature teeth with open apices.
    • Multi rooted teeth.
    • Pregnant women.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 3 patient groups

Conventional calcium hydroxide paste
Active Comparator group
Description:
Application of Conventional calcium hydroxide paste
Treatment:
Drug: Conventional calcium hydroxide paste
Calcium hydroxide nanoparticle
Experimental group
Description:
Application of Calcium hydroxide nanoparticle
Treatment:
Drug: Calcium hydroxide nanoparticle
Combined Calcium hydroxide with silver nanoparticle
Experimental group
Description:
Application of Combined Calcium hydroxide with silver nanoparticle
Treatment:
Drug: Combined Calcium hydroxide with silver nanoparticle

Trial contacts and locations

1

Loading...

Central trial contact

Reham Hassan, Assoc Prof; Mohamed Salah Hegazi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems